Focal dermal hypoplasia (FDH) or Goltz syndrome is a rare X-linked dominant multisystemic disease involving the ectoderm, mesoderm, and endoderm. About 95% of the cases appear de novo, and 90% of them are females. Recently, the studies revealed that FDH is caused by a mutation in the PORCN gene. We report a case of unilateral FDH or Goltz syndrome in a 16-year-old girl presenting with hypopigmented-reticulated atrophic macules and patches in a linear pattern distributed along the lines of Blaschko over the right side of the face and the right arm. Also she is having hypoplasia of the right breast with dental enamel abnormality and partial anodontia in the lower jaw. Sparse hair and partial alopecia on the right side (scalp, eyebrows, and eyelashes) were also observed.

2961-3035. 2. Peppercorn M A. Sulfasalazine: pharmacology, clinical use, toxicity and related new drug development. Ann Intern Med 1984: 101: 377-386. 3. Pullar T, Hunter J A, Capell H A. Sulfasalazine in rheumatoid arthritis: a double blind comparison of sulfasalazine with placebo and sodium aurothiomalate. Br Med J 1983: 287: 1102-1104. 4. Das K M, Eastwood M A, McManus J P A, Sircus W. Adverse reactions during salicylazosulfapyridine therapy SHORT COMMUNICATIONS and the relation with drug metabolism and acetylator phenotype. N Eng! J Med 1973: 289: 491-495. 5. Kanwar A J, Singh M, Yunus M, Belhaj M S. Fixed eruption to sulphasalazine. Dermatologica 1987: 174: 104. 6. Udono M, Murayama F, Tanioka H. Fixed drug eruption due to salazosulfapyridine and fixed drug eruption due to mefenamic acid. Medical Achievements of Sasebo City Hospital (in Japanese) 1991: 17: 57-61. 7. Hertl M, Jugert F, Merk H F. CDS+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermato/1995: 132: 215-220. 8. Hayllar J, Bjarnason I. Sulphasalazine in ulcerative colitis: in memoriam?

Flash Lamp Pulsed Dye Laser (FPDL) is a non-ablative technology that has an excellent reputation in vascular lesion treatment. It is always the first line treatment for scars; these can be successfully treated using different methods, such as ablative lasers or plastic surgery. 43 year old Saudi female known to have body dysmorphic disorder, had long history of repetitive plastic surgeries in different body sites came complaining of her inappropriate body shape and her weight planning for more plastic surgeries. Patients presented 9 months back complaining of multiple keloids at the sites of previous plastic surgeries. PDL 585 nm was started (fluence 4.0 j/cm, pulse width 20 ms, pulse rate 1.5 Hz). PDL showed subjective and clinically improvement in treating keloids, decreasing the size and thickness. Further trials are recommended to confirm our results.